Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 2c; Bumps FY Outlook Higher

Zimmer Biomet Holdings (NYSE: ZBH) reported Q3 EPS of $1.58, $0.02 better than the analyst estimate of $1.56. Revenue for the quarter came in at $1.67 billion versus the consensus estimate of $1.64 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2022 EPS of $6.80-$6.90, versus prior of $6.70-6.90 and the consensus of $6.79. Sees sales 0-1%, versus (1%)-1%.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• SanDisk stock target lifted at Bernstein to $3000 on new memory LTAs
• Xiaomi, Oppo, Vivo slash shipment targets up to 30% amid memory crunch - Nikkei
• Chip stocks hit record 19.7% of S&P 500, quadrupling since 2020